Epistemic AI is a platform that powers AI and NLP based applications in pharmaceuticals by merging and summarizing knowledge from multiple public and proprietary sources, and providing explainable insights for an optimal data-driven decision-making process. Epistemic AI’s first application allows biopharmaceutical companies and regulators to collect, characterize and evaluate sources of safety sentinels and signals for drug safety monitoring.

The startup represented here is a graduate of Endless Frontier Labs’ predecessor program, called Creative Destruction Lab-New York City, operated by NYU in partnership with University of Toronto during 2018-2019. The Endless Frontier Labs has no current engagement or affiliation with the Creative Destruction Lab.